Alpine Global Management, LLC Mirati Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$75.82 - $150.97 $1.14 Million - $2.27 Million	-15,062 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $1.99 Million - $2.87 Million	15,062 New	15,062 $2.21 Million
Q2 2021 Aug 13, 2021	SELL	$144.0 - $179.73 $385,200 - $480,777	-2,675 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$158.92 - $221.61 $425,110 - $592,806	2,675 New	2,675 $458,000
Q1 2018 May 16, 2018	SELL	$17.2 - $34.95 $317,718 - $645,596	-18,472 Closed	0 $0

Q4 2017 Feb 14, 2018	BUY	$12.65 - $19.0 $233,670 - $350,968	18,472	18,472 $337,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.